News Novartis drug effective in advanced MS Siponimod slowed disability progression in secondary progressive multiple sclerosis
News Scangos to leave Biogen at a crossroads Company has grown, but direction towards next stage is unclear
US FDA fast-tracks review of Roche's potential MS blockbuster Regulator to make decision by year end.
News Merck KGaA acquires MS brain training software provider Merck KGaA will now integrate the technology into its MSdialog platform.
News Dexcom is first to join FDA/CMS health tech pilot The FDA has named Dexcom as the first company to take part in its TEMPO pilot, which aims to bring digital health tech to patients more quickly.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
